Uniqure N.V. (QURE)

$27.00 +0.55 (2.08%)
Market Cap 1.67B
Revenue (ttm) 16.10M
Net Income (ttm) -198.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,235.84%
Debt to Equity Ratio 0.33
Volume 760,937
Avg Vol 1,761,570
Day's Range N/A - N/A
Shares Out 63.07M
Stochastic %K 35%
Beta 0.98
Analysts Strong Sell
Price Target $39.60

Company Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial t...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 20 240 6000
Address:
Paasheuvelweg 25, Amsterdam, Netherlands
Ontherag
Ontherag Jun. 8 at 6:11 PM
$QURE Path to commercialization went from 1 year to 5 years…cheerleading doesn’t matter
1 · Reply
PraxisTrade
PraxisTrade Jun. 8 at 9:53 AM
$NEON $LAC $QURE nm mn
0 · Reply
Aagam447
Aagam447 Jun. 4 at 6:41 PM
$QURE party over
0 · Reply
SwingTraderPro1
SwingTraderPro1 Jun. 4 at 4:17 PM
$QURE saw some noticeable flow hit yesterday, and now $CLPT is starting to get a bit of attention today with around 70K coming through Nothing massive yet, but this is how early rotation often starts. First one name gets active, then you start seeing spillover into related setups. Worth watching if this builds into something larger or just stays isolated flow. Either way, these are the kind of small signals traders use to track where attention is quietly shifting.
0 · Reply
Doozio
Doozio Jun. 4 at 2:39 PM
$CLPT has da huckleberries n that da $QURE ONTA 🐒🍌🧠⏰♾️
0 · Reply
Dkll303
Dkll303 Jun. 4 at 9:42 AM
$QURE Gee you thought there would be with Matt Kapushit selling every chance that ex broker gets He is no CEO ..he is using QURE as his private stock to control and keep scoring on options ….he even brags about it in close circles
0 · Reply
Dkll303
Dkll303 Jun. 4 at 9:40 AM
$BLUE $CRSP $QQQ $QURE $SPY And so dumb, BLUE was bought out 2 years ago for 300M ..all done there !
0 · Reply
Dkll303
Dkll303 Jun. 4 at 9:40 AM
$BLUE $QURE this @MF_DOOM character is a options player ..believe nothing he says …he has been here before touting higher prices and leaves when this hits $30 ..( use to be $25 ) so his rhetoric is garbage…
0 · Reply
topstockalerts
topstockalerts Jun. 4 at 2:24 AM
$QURE some charts shout. this one just quietly works. 📈
0 · Reply
MF__DOOM
MF__DOOM Jun. 3 at 10:07 PM
$QURE go long kid, I was thinking BO around $80-100 but we may not even need a BO for that price point to be obtainable now but I do still think a BO is possible and on the table here in the long term…let’s see as more time passes $BLUE $CRSP $SPY $QQQ
1 · Reply
Latest News on QURE
uniQure price target lowered to $50 from $70 at H.C. Wainwright

2026-05-07T03:31:34.000Z - 4 weeks ago

uniQure price target lowered to $50 from $70 at H.C. Wainwright

uniQure price target raised to $28 from $14 at Stifel

2026-05-05T15:40:54.000Z - 4 weeks ago

uniQure price target raised to $28 from $14 at Stifel

uniQure Earnings Call Transcript: Q1 2026

May 5, 2026, 8:30 AM EDT - 4 weeks ago

uniQure Earnings Call Transcript: Q1 2026

uniQure Earnings release: Q1 2026

May 5, 2026, 8:30 AM EDT - 4 weeks ago

uniQure Earnings release: Q1 2026

uniQure Quarterly report: Q1 2026

May 5, 2026, 8:30 AM EDT - 4 weeks ago

uniQure Quarterly report: Q1 2026

uniQure reports Q1 EPS (85c), consensus (75c)

2026-05-05T11:53:55.000Z - 4 weeks ago

uniQure reports Q1 EPS (85c), consensus (75c)

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

May 5, 2026, 7:05 AM EDT - 4 weeks ago

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

uniQure price target raised to $37 from $31 at Chardan

2026-04-30T22:15:49.000Z - 5 weeks ago

uniQure price target raised to $37 from $31 at Chardan

uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington's Disease

Apr 30, 2026, 7:05 AM EDT - 5 weeks ago

uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington's Disease

uniQure to Announce First Quarter 2026 Financial Results

Apr 28, 2026, 7:05 AM EDT - 5 weeks ago

uniQure to Announce First Quarter 2026 Financial Results

uniQure Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 6 weeks ago

uniQure Proxy statement: Proxy filing

uniQure Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 6 weeks ago

uniQure Proxy statement: Proxy filing

uniQure price target raised to $10 from $9 at Goldman Sachs

2026-04-20T10:22:30.000Z - 7 weeks ago

uniQure price target raised to $10 from $9 at Goldman Sachs

uniQure Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 7 weeks ago

uniQure Proxy statement: Proxy filing

uniQure put volume heavy and directionally bearish

2026-04-10T16:35:19.000Z - 2 months ago

uniQure put volume heavy and directionally bearish

uniQure put volume heavy and directionally bearish

2026-04-08T15:15:14.000Z - 2 months ago

uniQure put volume heavy and directionally bearish

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims

2026-03-24T16:34:35.000Z - 2 months ago

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims

uniQure price target lowered to $25 from $31 at Barclays

2026-03-23T09:35:09.000Z - 2 months ago

uniQure price target lowered to $25 from $31 at Barclays

uniQure upgraded to Outperform from Neutral at Mizuho

2026-03-10T20:27:50.000Z - 3 months ago

uniQure upgraded to Outperform from Neutral at Mizuho

This biotech's stock is soaring after a ‘polarizing' FDA official is stepping down

Mar 9, 2026, 9:18 AM EDT - 3 months ago

This biotech's stock is soaring after a ‘polarizing' FDA official is stepping down

Federal health officials attacked an Amsterdam-based biotech company seeking approval of a Huntington's disease treatment and accused it of lying

Mar 5, 2026, 6:01 PM EST - 3 months ago

Federal health officials attacked an Amsterdam-based biotech company seeking approval of a Huntington's disease treatment and accused it of lying

FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease

Mar 5, 2026, 2:42 PM EST - 3 months ago

FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease

Sr. FDA official calls Uniqure's Huntington's disease treatment a failure

Mar 5, 2026, 1:11 PM EST - 3 months ago

Sr. FDA official calls Uniqure's Huntington's disease treatment a failure

FDA official says UniQure fell short on Huntington's trial, defends new study request

Mar 4, 2026, 11:01 PM EST - 3 months ago

FDA official says UniQure fell short on Huntington's trial, defends new study request

uniQure Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 10:30 AM EST - 3 months ago

uniQure Transcript: TD Cowen 46th Annual Health Care Conference

uniQure Earnings Call Transcript: Q4 2025

Mar 2, 2026, 8:00 AM EST - 3 months ago

uniQure Earnings Call Transcript: Q4 2025

uniQure Earnings release: Q4 2025

Mar 2, 2026, 8:00 AM EST - 3 months ago

uniQure Earnings release: Q4 2025

uniQure Annual report: Q4 2025

Mar 2, 2026, 8:00 AM EST - 3 months ago

uniQure Annual report: Q4 2025

FDA tells UniQure study data insufficient for brain disorder therapy application

Mar 2, 2026, 7:22 AM EST - 3 months ago

FDA tells UniQure study data insufficient for brain disorder therapy application

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

Mar 2, 2026, 7:05 AM EST - 3 months ago

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

Feb 25, 2026, 6:00 PM EST - 3 months ago

QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

uniQure to Announce 2025 Financial Results

Feb 23, 2026, 7:05 AM EST - 3 months ago

uniQure to Announce 2025 Financial Results

UniQure N.V. (QURE) Securities Fraud: Contact Berger Montague To Discuss Your Rights

Feb 18, 2026, 10:06 AM EST - 3 months ago

UniQure N.V. (QURE) Securities Fraud: Contact Berger Montague To Discuss Your Rights

UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large Losses in uniQure N.V.

Feb 17, 2026, 8:16 AM EST - 3 months ago

UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large Losses in uniQure N.V.

uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

Feb 6, 2026, 7:05 AM EST - 4 months ago

uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

uniQure Slides: Corporate presentation

Jan 13, 2026, 7:00 AM EST - 5 months ago

uniQure Slides: Corporate presentation

uniQure Announces Type A Meeting Scheduled with FDA

Jan 9, 2026, 7:05 AM EST - 5 months ago

uniQure Announces Type A Meeting Scheduled with FDA

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Dec 7, 2025, 12:01 PM EST - 6 months ago

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Dec 4, 2025, 7:05 AM EST - 6 months ago

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

Nov 14, 2025, 4:17 AM EST - 7 months ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

uniQure Earnings Call Transcript: Q3 2025

Nov 10, 2025, 8:30 AM EST - 7 months ago

uniQure Earnings Call Transcript: Q3 2025

uniQure Quarterly report: Q3 2025

Nov 10, 2025, 8:30 AM EST - 7 months ago

uniQure Quarterly report: Q3 2025

uniQure Earnings release: Q3 2025

Nov 10, 2025, 8:30 AM EST - 7 months ago

uniQure Earnings release: Q3 2025

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:05 AM EST - 7 months ago

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

uniQure to Announce Third Quarter 2025 Financial Results

Nov 6, 2025, 7:05 AM EST - 7 months ago

uniQure to Announce Third Quarter 2025 Financial Results

Ontherag
Ontherag Jun. 8 at 6:11 PM
$QURE Path to commercialization went from 1 year to 5 years…cheerleading doesn’t matter
1 · Reply
PraxisTrade
PraxisTrade Jun. 8 at 9:53 AM
$NEON $LAC $QURE nm mn
0 · Reply
Aagam447
Aagam447 Jun. 4 at 6:41 PM
$QURE party over
0 · Reply
SwingTraderPro1
SwingTraderPro1 Jun. 4 at 4:17 PM
$QURE saw some noticeable flow hit yesterday, and now $CLPT is starting to get a bit of attention today with around 70K coming through Nothing massive yet, but this is how early rotation often starts. First one name gets active, then you start seeing spillover into related setups. Worth watching if this builds into something larger or just stays isolated flow. Either way, these are the kind of small signals traders use to track where attention is quietly shifting.
0 · Reply
Doozio
Doozio Jun. 4 at 2:39 PM
$CLPT has da huckleberries n that da $QURE ONTA 🐒🍌🧠⏰♾️
0 · Reply
Dkll303
Dkll303 Jun. 4 at 9:42 AM
$QURE Gee you thought there would be with Matt Kapushit selling every chance that ex broker gets He is no CEO ..he is using QURE as his private stock to control and keep scoring on options ….he even brags about it in close circles
0 · Reply
Dkll303
Dkll303 Jun. 4 at 9:40 AM
$BLUE $CRSP $QQQ $QURE $SPY And so dumb, BLUE was bought out 2 years ago for 300M ..all done there !
0 · Reply
Dkll303
Dkll303 Jun. 4 at 9:40 AM
$BLUE $QURE this @MF_DOOM character is a options player ..believe nothing he says …he has been here before touting higher prices and leaves when this hits $30 ..( use to be $25 ) so his rhetoric is garbage…
0 · Reply
topstockalerts
topstockalerts Jun. 4 at 2:24 AM
$QURE some charts shout. this one just quietly works. 📈
0 · Reply
MF__DOOM
MF__DOOM Jun. 3 at 10:07 PM
$QURE go long kid, I was thinking BO around $80-100 but we may not even need a BO for that price point to be obtainable now but I do still think a BO is possible and on the table here in the long term…let’s see as more time passes $BLUE $CRSP $SPY $QQQ
1 · Reply
Trader205835
Trader205835 Jun. 3 at 10:04 PM
$QURE is there really no AH action?
0 · Reply
MF__DOOM
MF__DOOM Jun. 3 at 10:02 PM
$QURE 👀 $SPY $QQQ Rip $BLUE $CRSP
0 · Reply
Aagam447
Aagam447 Jun. 3 at 8:13 PM
$QURE no after hour action
0 · Reply
hdztradelife
hdztradelife Jun. 3 at 7:49 PM
$QQQ just sample what i traded today $NVTS, $SNDK, $QURE 🤷🏽‍♂️🤷🏽‍♂️🤷🏽‍♂️
0 · Reply
Thinkingman91
Thinkingman91 Jun. 3 at 7:05 PM
$QURE follow the posts
0 · Reply
aristocks
aristocks Jun. 3 at 6:28 PM
Sometimes the simplest thing in life are the best! Major level right here for $QURE Looking for a break out above AVWAP and short term PT at 39$. After that I and depending on any news, I see creeping up back to 70$. BOught at 40s and loaded at 9$... So feeling great for the moment :) Not financial advice. Do your own DD.
0 · Reply
LotOfAction
LotOfAction Jun. 3 at 6:24 PM
$QURE I added more on this rise - lot of new stuff on the FDA webpage today that bodes extremely well for this ….
0 · Reply
Herrfranz
Herrfranz Jun. 3 at 6:21 PM
$QURE added 200 shares
0 · Reply
daticecold
daticecold Jun. 3 at 5:11 PM
$QURE Attention Everyone. I am back in UniQure after it broke my heart 6 months ago. Same position size in shares. Same mindset (Money). This is going to be very special now that Makary and his goons are gone.
0 · Reply
MAGA1717
MAGA1717 Jun. 3 at 2:25 PM
$QURE oh yes BB
0 · Reply
LotOfAction
LotOfAction Jun. 3 at 1:46 PM
$QURE $CLPT
0 · Reply
jewell69
jewell69 Jun. 2 at 4:34 PM
did everybody notice that $XBI is -4.02% today 6/2/26 as of 12:32 pm EDT biotech. stocks I've done in the past but dont own now: $SRPT -7.84% $QURE -5.95% $BEAM -5.33% $NTLA -4.95%
2 · Reply